Navigation Links
Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
Date:3/24/2009

Response to March 24 article in the New England Journal of Medicine

ALEXANDRIA, Va. and JACKSONVILLE, Fla., March 24 /PRNewswire-USNewswire/ -- A study published online today in the New England Journal of Medicine suggests that intensive blood glucose (sugar) control for critical care patients with hyperglycemia (high blood glucose) does not improve outcomes and is associated with an increase in deaths.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-a)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

The American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) maintain that the findings of the Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation (NICE-SUGAR) study should NOT lead to an abandonment of the concept of good glucose management in the hospital setting. Uncontrolled high blood glucose can lead to serious problems for hospitalized patients, such as dehydration and increased propensity to infection.

It is important to consider that the severely ill patients in this trial were treated intensively with intravenous insulin to very tight targets (average of 115 mg/dl), and were compared to a control group whose glucose control was good (average glucose 144 mg/dl).

The ADA and AACE caution against letting this study swing the pendulum of glucose control too far in the other direction where providers in hospitals are complacent about uncontrolled hyperglycemia. The two organizations maintain that strategies must be identified to help hospitals establish structured protocols for safe and effective management of blood glucose in both int
'/>"/>

SOURCE American Association of Clinical Endocrinologists; American Diabetes Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
2. Octogenarians: Not Too Old for Joint Replacement
3. Beating Blood Clots after Joint Replacement
4. When to Have That Joint Replacement?
5. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
6. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
7. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
10. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
11. Joint Commission Urges Patients to Speak Up About Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) ... offering of 21,250,000 shares of its common stock and warrants ... of approximately $17.0 million.  The securities sold in the offering ... a warrant to purchase 0.5 of a share at a ...
... 16, 2011 The federal government,s tracking system for ... to account for a new procurement policy implemented last ... higher number of power wheelchairs provided than were actually ... and manufacturers report declines of 30 percent or more ...
Cached Medicine Technology:ADVENTRX Announces Closing of Public Offering 2ADVENTRX Announces Closing of Public Offering 3American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 3American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 4
(Date:7/9/2014)... Medicine at the University of Pennsylvania in collaboration with ... million grant from the National Cancer Institute (NCI) to ... patients with malignant pleural mesothelioma, a rare, aggressive and ... lining of the lungs and is caused almost exclusively ... clinical trial and additional studies looking at the effects ...
(Date:7/9/2014)... almost all types of cancer sends the protein factories ... a tumour,s uncontrolled growth, new research suggests. , Scientists ... molecular trigger responsible for ratcheting up activity of the ... the building blocks cancer cells need to keep growing. ... SREBP, controls the flow of messages to the endoplasmic ...
(Date:7/9/2014)... cancer, researchers have uncovered mutations in a cell-signaling pathway ... knowledge may expand treatments for patients because drugs targeting ... are in clinical trials. , Reporting July 9 in ... (TCGA), including researchers at Washington University School of Medicine ... studied tumors from 230 patients with lung adenocarcinoma. , ...
(Date:7/9/2014)... Chase Cancer Center paint a relatively optimistic picture of ... that have spread to the chest wall or skin, ... the skin, regardless of size and whether they have ... and called "locally advanced" tumors, suggesting that they ... poor survival. Locally advanced breast cancers of this and ...
(Date:7/9/2014)... injection drug users in Russia might contribute to ... study, conducted by researchers from Boston University Schools ... St. Petersburg Pavlov State University, sought to discover ... outcomes of a cohort of HIV-positive people with ... were arrested by police were more likely to ...
Breaking Medicine News(10 mins):Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Lung cancer study hints at new treatments 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2
... PITTSBURGH, May 23 The risk of acquiring HIV through ... with unprotected vaginal sex and increases if other infections are ... lubricants at least certain kinds be another risk ... intercourse? Two studies presented today at the International Microbicides Conference ...
... -- Fasten your seatbelt. Get that flu shot. Eat ... you,re not in the room. Save money for your retirement. ... that social marketing can seek to influence. When public health, ... next month for the 20th Anniversary Social Marketing in Public ...
... ... heroic veterans. , ... 25, 2010 -- Memorial Day weekend we celebrate the lives of countless heroes who have sacrificed ... is to take it one step further than attending parades and barbeque,s, we want to bring ...
... ... and chemical dependence agencies using a wide variety of mobile devices and smartphones ... DeWitt, NY & ... and Canvas ( www.GoCanvas.com ) today announced today a collaboration that provides JAG clients ...
... ... , ... (PRWEB) -- In stark contrast to rising U.S. brand name drug prices, prices on brand ... according to analyses by PharmacyChecker.com , the leading independent evaluator of online pharmacies. ...
... study finds, , TUESDAY, May 25 (HealthDay News) -- ... Alzheimer,s disease among otherwise healthy people, a new Spanish ... gain the most benefit from alcohol consumption, according to ... Valencia government and the Municipal Institute of Medical Investigation ...
Cached Medicine News:Health News:Use of lubricants with anal sex could increase risk of HIV 2Health News:Use of lubricants with anal sex could increase risk of HIV 3Health News:Use of lubricants with anal sex could increase risk of HIV 4Health News:Use of lubricants with anal sex could increase risk of HIV 5Health News:Use of lubricants with anal sex could increase risk of HIV 6Health News:Social marketing changes with times to promote social change 2Health News:Social marketing changes with times to promote social change 3Health News:BuyDirectUSA.com Launches 'Operation Honor a Veteran' 2Health News:Mobile Clinic Management EMR for Patient Health Information Launched by JAG Products and Canvas Partnership 2Health News:Mobile Clinic Management EMR for Patient Health Information Launched by JAG Products and Canvas Partnership 3Health News:Mobile Clinic Management EMR for Patient Health Information Launched by JAG Products and Canvas Partnership 4Health News:PharmacyChecker.com Reports Decrease in Brand Name Drug Prices From Canadian and Other International Online Pharmacies 2Health News:PharmacyChecker.com Reports Decrease in Brand Name Drug Prices From Canadian and Other International Online Pharmacies 3Health News:Moderate Drinking May Protect Brain From Alzheimer's 2
... special order products are offered as 1-piece ... lengths. The modular instruments may be customized ... such as ratchets, insulation and flush ports. ... stock. Customer specifications may affect delivery times. ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... offered as 1-piece or modular, in regular ... may be customized with handles of choice ... and flush ports. Many standard patterns are ... affect delivery times. , Please Note: ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
Medicine Products: